CTC
AMAG

Central Trust Company’s AMAG Pharmaceuticals AMAG Stock Holding History

Central Trust Company’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,003
Closed -$30K – 1190
2015
Q4 		$30K Buy
1,003
+664
+196% +$21.5K ﹤0.01% 774
2015
Q3 		$13K Buy
+339
New +$21K ﹤0.01% 935

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Central Trust Company's AMAG Position: Q1 2016 in Review

Central Trust Company sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 1,003 shares — an estimated $30K sold.

Central Trust Company first reported a position in AMAG in Q3 2015 and held it in 2 quarters. The position peaked at $30K in Q4 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Central Trust Company reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Central Trust Company sold 1,003 AMAG Pharmaceuticals shares in Q1 2016, an estimated $30K.
  • Central Trust Company first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Central Trust Company's AMAG Pharmaceuticals position peaked at $30K in Q4 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Central Trust Company's 13F filing for Q1 2016, filed 11 Apr 2016.